子宫肌瘤的自我管理与护理
Self-Management and Care of Uterine Fibroids
DOI: 10.12677/acm.2025.15113300, PDF,   
作者: 阿尔达克·库勒麦提汗, 郑丽萍*:新疆生产建设兵团医院妇产科,新疆 乌鲁木齐
关键词: 子宫肌瘤护理Uterine Fibroids Nursing
摘要: 目的:帮助患者正确认识子宫肌瘤,减少不必要的恐慌。方法:子宫肌瘤的自我管理是一个综合性策略,关键在于定期监测症状并遵医嘱定期复查、调整饮食、控制体重、正确的压力管理与心理调适、谨慎使用激素类药物等,患者在日常生活中进行有效的自我管理与护理,对于缓解症状、延缓肌瘤生长、改善身心状态及提升整体生活质量,扮演着至关重要的辅助角色。结果:通过长期、系统地践行上述自我管理策略,患者有望在很多方面获得积极改善。结论:子宫肌瘤作为一种慢性状况,其管理是一个长期的过程。通过科学的自我管理与专业的医疗护理,在与子宫肌瘤共存的日子里,每一位女性都能拥有更高的生活质量和更积极的人生姿态。
Abstract: Objective: To help patients correctly understand uterine fibroids and reduce unnecessary panic. Methods: Self-management of uterine fibroids is a comprehensive strategy, the key is to regularly monitor symptoms and follow the doctor’s advice, adjust diet, control weight, correct stress management and psychological adjustment, and prudent use of hormonal drugs. Results: By practicing the above self-management strategies over a long period of time and systematically, patients are expected to achieve positive improvement in many aspects. Conclusion: As a chronic condition, the management of uterine fibroids is a long-term process. Through scientific self-management and professional medical care, every woman can have a higher quality of life and a more positive attitude towards life in the days of coexistence with uterine fibroids.
文章引用:阿尔达克·库勒麦提汗, 郑丽萍. 子宫肌瘤的自我管理与护理[J]. 临床医学进展, 2025, 15(11): 1912-1916. https://doi.org/10.12677/acm.2025.15113300

参考文献

[1] Day Baird, D., Dunson, D.B., Hill, M.C., Cousins, D. and Schectman, J.M. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics and Gynecology, 188, 100-107. [Google Scholar] [CrossRef] [PubMed]
[2] Vilos, G.A., Allaire, C., Laberge, P., Leyland, N., Vilos, A.G., Murji, A., et al. (2015) The Management of Uterine Leiomyomas. Journal of Obstetrics and Gynaecology Canada, 37, 157-178. [Google Scholar] [CrossRef] [PubMed]
[3] National Institute for Health and Care Excellence (2007) Heavy Menstrual Bleeding. Clinical Guideline CG44.
http://guidance.nice.org.uk/CG44
[4] Spitz, I.M. (2009) Clinical Utility of Progesterone Receptor Modulators and Their Effect on the Endometrium. Current Opinion in Obstetrics & Gynecology, 21, 318-324. [Google Scholar] [CrossRef] [PubMed]
[5] Maruo, T. (2000) Effects of Progesterone on Uterine Leiomyoma Growth and Apoptosis. Steroids, 65, 585-592. [Google Scholar] [CrossRef] [PubMed]
[6] Donnez, J., Tatarchuk, T.F., Bouchard, P., Puscasiu, L., Zakharenko, N.F., Ivanova, T., et al. (2012) Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery. New England Journal of Medicine, 366, 409-420. [Google Scholar] [CrossRef] [PubMed]
[7] Donnez, J., Tomaszewski, J., Vázquez, F., Bouchard, P., Lemieszczuk, B., Baró, F., et al. (2013) Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids. Obstetrical & Gynecological Survey, 68, 99-100. [Google Scholar] [CrossRef